1. Home
  2. VRPX
  3. VRPX News

Latest Virpax Pharmaceuticals Inc. (VRPX) News on July 26, 2024

Virpax Regains Compliance with Nasdaq Minimum Bid Price
VRPX

Business Wire

3 days ago

Virpax Regains Compliance with Nasdaq Minimum Bid Price

Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?
VRPX

Benzinga

16 days ago

Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?

VRPX

MT Newswires

16 days ago

Virpax Says Non-Narcotic Pain Medication Shows Positive Results in Swine Model Study; Shares Rise

Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™
VRPX

Business Wire

17 days ago

Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™

Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding
VRPX

Business Wire

19 days ago

Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding

Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
VRPX

Business Wire

2 months ago

Virpax® Pharmaceuticals to Present at 2024 BIO International Convention

VRPX

MT Newswires

2 months ago

Virpax Prices Public Offering of Shares, Warrants; Shares Tumble

VRPX

MT Newswires

2 months ago

Top Premarket Decliners

Virpax Announces Pricing of $2.25 Million Public Offering
VRPX

Business Wire

2 months ago

Virpax Announces Pricing of $2.25 Million Public Offering

Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments
VRPX

Business Wire

2 months ago

Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
VRPX

Business Wire

3 months ago

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™

Virpax Pharmaceuticals Reports 2023 Year-End Results
VRPX

Business Wire

4 months ago

Virpax Pharmaceuticals Reports 2023 Year-End Results

Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
VRPX

Business Wire

5 months ago

Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price

Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
VRPX

Business Wire

5 months ago

Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.

Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
VRPX

Business Wire

6 months ago

Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research

SRM Entertainment Showcases New Products at the 2024 Las Vegas Winter Market Gift Show
VRPX

GlobeNewswire

6 months ago

SRM Entertainment Showcases New Products at the 2024 Las Vegas Winter Market Gift Show

Best Momentum Stocks to Buy for January 26th
VRPX

Zacks

6 months ago

Best Momentum Stocks to Buy for January 26th

WISeKey Joins Global Mergers, Acquisitions & Investment Council (GMAIC)
VRPX

GlobeNewswire

6 months ago

WISeKey Joins Global Mergers, Acquisitions & Investment Council (GMAIC)

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
VRPX

GlobeNewswire

6 months ago

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

SurgePays Acquires ClearLine Mobile
VRPX

GlobeNewswire

7 months ago

SurgePays Acquires ClearLine Mobile

Are You Looking for a Top Momentum Pick? Why BTCS Inc. (BTCS) is a Great Choice
VRPX

Zacks

7 months ago

Are You Looking for a Top Momentum Pick? Why BTCS Inc. (BTCS) is a Great Choice

CervoMed to Participate in the Emerging Growth Conference 66
VRPX

GlobeNewswire

7 months ago

CervoMed to Participate in the Emerging Growth Conference 66

Eco Wave Power Commences Sending of Clean Electricity to the Israeli National Electrical Grid
VRPX

PR Newswire

7 months ago

Eco Wave Power Commences Sending of Clean Electricity to the Israeli National Electrical Grid

New Study Reports IceCure's ProSense® Boosts Immune Response Against Cancer: Enhances CD8+ T Cell Response
VRPX

PR Newswire

7 months ago

New Study Reports IceCure's ProSense® Boosts Immune Response Against Cancer: Enhances CD8+ T Cell Response

Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
VRPX

GlobeNewswire

7 months ago

Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients
VRPX

GlobeNewswire

7 months ago

Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients

Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting
VRPX

Business Wire

7 months ago

Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting

Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
VRPX

GlobeNewswire

7 months ago

Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer

Inpixon Announces That Damon Motors Will Feature Its HyperFighter Superbike at CES 2024
VRPX

PR Newswire

7 months ago

Inpixon Announces That Damon Motors Will Feature Its HyperFighter Superbike at CES 2024

Aclaris Therapeutics Provides Corporate Update
VRPX

GlobeNewswire

7 months ago

Aclaris Therapeutics Provides Corporate Update

Cepton Inc's Chief Commercial Officer Reveals Cost-Efficient Innovations and Strategic Partnerships
VRPX

News Direct

7 months ago

Cepton Inc's Chief Commercial Officer Reveals Cost-Efficient Innovations and Strategic Partnerships

Take Care Before Diving Into The Deep End On Concord Medical Services Holdings Limited (NYSE:CCM)
VRPX

Simply Wall St.

7 months ago

Take Care Before Diving Into The Deep End On Concord Medical Services Holdings Limited (NYSE:CCM)

Veru Announces Pricing of Public Offering of Common Stock
VRPX

GlobeNewswire

7 months ago

Veru Announces Pricing of Public Offering of Common Stock

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia
VRPX

GlobeNewswire

7 months ago

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia

Study Using IceCure's ProSense® Finds: "Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients"
VRPX

PR Newswire

7 months ago

Study Using IceCure's ProSense® Finds: "Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients"

Pennsylvania-based Health System Expands Relationship With Streamline Health® eValuator™ Pro-Fee Module
VRPX

GlobeNewswire

7 months ago

Pennsylvania-based Health System Expands Relationship With Streamline Health® eValuator™ Pro-Fee Module

Solitario CEO to Present at John Tumazos Very Independent Research, LLC Virtual Conference
VRPX

ACCESSWIRE

8 months ago

Solitario CEO to Present at John Tumazos Very Independent Research, LLC Virtual Conference

Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting
VRPX

GlobeNewswire

8 months ago

Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting

Altisource Asset Management Corporation Announces Departure of COO and Interim CEO Danya Sawyer
VRPX

Business Wire

8 months ago

Altisource Asset Management Corporation Announces Departure of COO and Interim CEO Danya Sawyer

Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
VRPX

Zacks

8 months ago

Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data

Leading Tier 1 European Mobile Operator Signs New SafePath® Multiyear Contract with Smith Micro
VRPX

Business Wire

8 months ago

Leading Tier 1 European Mobile Operator Signs New SafePath® Multiyear Contract with Smith Micro

Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
VRPX

GlobeNewswire

8 months ago

Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress

Altisource Asset Management Corporation Reports Receipt of Communications from NYSE
VRPX

Business Wire

8 months ago

Altisource Asset Management Corporation Reports Receipt of Communications from NYSE

Daré Bioscience Announces Commencement of Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Intravaginal Contraceptive
VRPX

GlobeNewswire

8 months ago

Daré Bioscience Announces Commencement of Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Intravaginal Contraceptive

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
VRPX

Business Wire

8 months ago

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

Rallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
VRPX

Business Wire

8 months ago

Rallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia

VRPX

Associated Press Finance

8 months ago

Bright Scholar: Fiscal Q4 Earnings Snapshot

VRPX

PR Newswire

8 months ago

Bright Scholar Announces Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year 2023

Remark Holdings, Inc. (NASDAQ:MARK) Q3 2023 Earnings Call Transcript
VRPX

Insider Monkey

8 months ago

Remark Holdings, Inc. (NASDAQ:MARK) Q3 2023 Earnings Call Transcript

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2023 Earnings Call Transcript
VRPX

Insider Monkey

8 months ago

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2023 Earnings Call Transcript

Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
VRPX

Business Wire

8 months ago

Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing

Virpax Pharmaceuticals Announces Leadership Transition
VRPX

Business Wire

8 months ago

Virpax Pharmaceuticals Announces Leadership Transition

Astra Announces Third Quarter 2023 Financial Results
VRPX

Business Wire

8 months ago

Astra Announces Third Quarter 2023 Financial Results

Several Insiders Invested In SHF Holdings Flagging Positive News
VRPX

Simply Wall St.

8 months ago

Several Insiders Invested In SHF Holdings Flagging Positive News

Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
VRPX

Business Wire

8 months ago

Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments

VRPX

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Kingstone Companies Inc Earnings Call

Dragonfly Energy Reports Third Quarter 2023 Financial and Operational Results
VRPX

GlobeNewswire

8 months ago

Dragonfly Energy Reports Third Quarter 2023 Financial and Operational Results

Future FinTech Announces the Closing of the Acquisition of Alpha International Securities (Hong Kong) Ltd.
VRPX

PR Newswire

8 months ago

Future FinTech Announces the Closing of the Acquisition of Alpha International Securities (Hong Kong) Ltd.

Bearish: Analysts Just Cut Their Smith Micro Software, Inc. (NASDAQ:SMSI) Revenue and EPS estimates
VRPX

Simply Wall St.

8 months ago

Bearish: Analysts Just Cut Their Smith Micro Software, Inc. (NASDAQ:SMSI) Revenue and EPS estimates

CareMax, Inc. (NASDAQ:CMAX) Q3 2023 Earnings Call Transcript
VRPX

Insider Monkey

8 months ago

CareMax, Inc. (NASDAQ:CMAX) Q3 2023 Earnings Call Transcript

Sadot Group Inc. Announces Third Quarter 2023 Conference Call
VRPX

ACCESSWIRE

9 months ago

Sadot Group Inc. Announces Third Quarter 2023 Conference Call

Wood Pellet Exporter Enviva's Stock Is Tumbling Again
VRPX

The Wall Street Journal

9 months ago

Wood Pellet Exporter Enviva's Stock Is Tumbling Again

VRPX

Associated Press Finance

9 months ago

Aptose Biosciences: Q3 Earnings Snapshot

Kingstone Announces 2023 Third Quarter Financial Results
VRPX

ACCESSWIRE

9 months ago

Kingstone Announces 2023 Third Quarter Financial Results

Cheetah Net Supply Chain Service Inc. Announces Third Quarter 2023 Results
VRPX

GlobeNewswire

9 months ago

Cheetah Net Supply Chain Service Inc. Announces Third Quarter 2023 Results

Aptose Reports Results for the Third Quarter 2023
VRPX

GlobeNewswire

9 months ago

Aptose Reports Results for the Third Quarter 2023

VRPX

GuruFocus.com

9 months ago

CareMax Inc (CMAX) Reports Growth Amidst Challenges in Q3 2023

Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates
VRPX

Business Wire

9 months ago

Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates

CareMax Reports Third Quarter 2023 Results
VRPX

Business Wire

9 months ago

CareMax Reports Third Quarter 2023 Results

Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023
VRPX

Business Wire

9 months ago

Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023

Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®
VRPX

Business Wire

9 months ago

Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®

Share on Social Networks: